Publications by authors named "Auro Viswabandya"

110 Publications

Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely option.

Am J Hematol 2021 02 10;96(2):179-187. Epub 2020 Nov 10.

Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
February 2021

Prolactin, a potential biomarker for chronic GVHD activity.

Eur J Haematol 2021 Feb 26;106(2):158-164. Epub 2020 Oct 26.

Section of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
February 2021

Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant.

Eur J Haematol 2021 Jan 13;106(1):32-39. Epub 2020 Oct 13.

Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF
January 2021

Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous Leukemia.

Biol Blood Marrow Transplant 2020 08 16;26(8):1511-1519. Epub 2020 May 16.

Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Hematology Department, Institut CatalĂ  d'Oncologia-Hospitalet, IDIBELL, Barcelona, Spain.

View Article and Find Full Text PDF
August 2020

Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation.

Eur J Haematol 2020 Jul 18;105(1):24-29. Epub 2020 Mar 18.

Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.

View Article and Find Full Text PDF
July 2020

Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD.

Bone Marrow Transplant 2020 09 5;55(9):1773-1783. Epub 2020 Feb 5.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF
September 2020

Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients.

Transplantation 2020 02;104(2):404-409

Transplant Infectious Diseases, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF
February 2020

My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults.

Bone Marrow Transplant 2020 05 14;55(5):867-872. Epub 2019 Oct 14.

Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF
May 2020

Dual T Cell Depletion with Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide Results in Low Rates of Cytokine Release Syndrome in Peripheral Blood Haplo-Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2019 12 14;25(12):e387-e388. Epub 2019 Sep 14.

Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Electronic address:

View Article and Find Full Text PDF
December 2019

Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis.

Eur J Haematol 2019 Dec 30;103(6):597-606. Epub 2019 Sep 30.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF
December 2019

Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.

Eur J Haematol 2019 Nov 9;103(5):510-518. Epub 2019 Sep 9.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF
November 2019

Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking acute graft versus host disease.

Eur J Haematol 2019 Nov 27;103(5):519-522. Epub 2019 Aug 27.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.

View Article and Find Full Text PDF
November 2019

Impressive Graft-versus-Host Disease-Free, Relapse-Free Survival in Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning and a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide.

Biol Blood Marrow Transplant 2019 11 4;25(11):e352-e353. Epub 2019 Jul 4.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
November 2019

Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants.

Eur J Haematol 2019 Jun 29;102(6):486-493. Epub 2019 Apr 29.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
June 2019